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Summary
The regulation and stem cell origin of normal and neoplastic gastric glands are uncertain. Here, we 
show that Mist1 expression marks quiescent stem cells in the gastric corpus isthmus. Mist1+ stem 
cells serve as a cell-of-origin for intestinal-type cancer with the combination of Kras and Apc 
mutation, and for diffuse-type cancer with the loss of E-cadherin. Diffuse-type cancer 
development is dependent on inflammation mediated by Cxcl12+ endothelial cells and Cxcr4+ 
gastric innate lymphoid cells (ILCs). These cells form the perivascular gastric stem cell niche, and 
Wnt5a produced from ILCs activates RhoA to inhibit anoikis in the E-cadherin-depleted cells. 
Targeting Cxcr4, ILCs, or Wnt5a inhibits diffuse-type gastric carcinogenesis, providing targets 
within the neoplastic gastric stem cell niche.
Graphical Abstract
Introduction
Gastric cancer is the third most frequent cause of cancer death worldwide. In the gastric 
corpus within the proximal stomach, the glands contain chief cells that are important for 
digestion, and parietal cells that are vital for acid production, controlled in part by 
enterochromaffin-like (ECL) cells. There are also intervening mucous neck cells, above 
which are the superficial pits that are lined by pit cell epithelium. Despite abundant literature 
on small intestinal stem cells (ISCs), an infrequent site of human cancer, there have been 
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relatively few studies addressing the stem cells that maintain the normal and neoplastic 
gastric epithelium.
Tissue stem cells maintain the integrity of rapidly proliferating tissues such as the 
gastrointestinal epithelium, residing within a stem cell niche. Replicative quiescence and a 
relatively undifferentiated morphology have generally been considered cardinal properties of 
adult stem cells (Malam and Cohn, 2014; Mills and Shivdasani, 2011). In the gastric corpus, 
earlier radiolabeling and electron microscopy studies suggest a single undifferentiated, 
“granule-free” cell as the putative stem cell in the isthmus of each gastric unit of the mouse 
(Karam and Leblond, 1993; Mills and Shivdasani, 2011). Studies suggest that within the 
corpus isthmus, Sox2+ cells may be long-lived stem cells, while Tff2+ cells are relatively 
short-lived progenitors (Arnold et al., 2011; Quante et al., 2010). More recently, a “reserve 
stem-like cell” population expressing Troy or Mist1 was postulated to reside at the base of 
corpus gland (Stange et al., 2013).
Gastric cancer is classified into an intestinal-type and a diffuse-type, and carcinogenesis in 
the stomach is strongly associated with chronic inflammation. Oncogenic mutations such as 
Kras and Apc targeted to gastric stem/progenitor cells led to intestinal-type metaplasia or 
dysplasia in mice (Barker et al., 2010; Okumura et al., 2010). By contrast, the E-cadherin 
gene (CDH1) is frequently mutated or down-regulated in diffuse-type gastric cancer (DGC) 
(Guilford et al., 1998). In a rodent model, knockout of Cdh1 was insufficient to initiate 
gastric tumors, but did predispose to the development of DGC with signet-ring cells 
following additional genetic events (Shimada et al., 2012). Studies of prophylactic 
gastrectomy specimens from germline carriers of CDH1 mutations have revealed that DGC 
appears to arise in the proximal gastric isthmus (Humar et al., 2007), but the cellular origin 
of all gastric cancers remains unknown.
Tissue stem cells and cancer development are maintained by their niche. The Wnt signaling 
pathway plays a central role in the maintenance of ISCs, which are supported by the ISC 
niche, including both Paneth cells (Sato et al., 2011) and the surrounding mesenchyme 
(Farin et al., 2012). However, the gastric corpus does not normally depend on the Wnt 
pathway (Mills and Shivdasani, 2011), and therefore the critical pathway regulating corpus 
stem cell niche is largely unknown. In the gut mesenchyme, several cell types including 
pericytes, nerves, or mesothelial cells (Miyoshi et al., 2012; Worthley et al., 2015; Zhao et 
al., 2014) are reported to maintain tissue stem cells and contribute to cancer development. In 
the bone marrow, perivascular stromal cells including endothelial cells, Cxcl12-abundant 
reticular (CAR) cells, and nerves, promote hematopoietic stem cell (HSC) maintenance and 
neoplastic changes through the production of cytokines or chemokines such as Cxcl12 or 
SCF (Hanoun et al., 2014; Mendelson and Frenette, 2014; Pitt et al., 2015). However, 
whether such stromal factors play a role in the normal and neoplastic gut stem cell niche 
remains unclear.
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Mist1 is a marker of quiescent stem cells in the gastric corpus isthmus
We utilized Mist1-CreERT2 knockin mice, where Cre recombinase is induced by tamoxifen 
(TAM) in cells expressing a bHLH transcription factor Mist1, and investigated the 
contribution of Mist1+ “reserve stem-like” chief cells to gastric carcinogenesis. To clarify 
the expression pattern of Mist1 in the normal stomach, we crossed Mist1-CreERT2 mice 
with R26-mTmG mice. This reporter features the dichotomous expression of red (without 
recombination) or green fluorescence (with recombination). Most of the recombined Mist1+ 
cells were detected in mature chief cells in the lower third of the glands (position 1–14) 1 
day after TAM induction, (Figure 1A). However, Mist1+ recombined cells were also evident 
as rare single cells in the isthmus. Recombination in the isthmus was observed in either R26-
TdTomato or R26-LacZ mice, or with low dose TAM (1 mg) (Figure S1A). Endogenous 
Mist1 expression in the isthmus was confirmed by in situ hybridization (Figure S1B). Their 
electron microscopy appearance was similar to the “granule free” stem cells previously 
reported (Karam and Leblond, 1993) (Figure 1B).
The GFP+ Mist1 lineage expanded gradually over 540 days (Figure 1C–1D). In contrast to a 
previous report (Stange et al., 2013), our detailed time course revealed bi-directional 
expansion from single Mist1+ cells at position 25–30 in the isthmus, both upward towards 
the lumen and deeper into the gland, independent of the dose of TAM (Figure S1C). The 
approximate doubling time of Mist1+ isthmus cells is 120 hours or 5 days (Figure S1D), and 
these cells first divided into isthmus progenitors with small or spindle appearance (Figure 
S1E), followed later by the differentiation into surface pit and neck cells, and subsequently 
into parietal cells. Over time, the number of GFP+ cells in the chief cell region declines 
whilst the isthmus clone expands (Figure 1D). Lineage tracing persisted beyond 18 months 
post-induction with whole labeled corpus glands, proving that Mist1+ cells self-renew 
(Figure 1E). Mist1-CreERT2;R26-Confetti mice show that single-color clonal expansion is 
seen predominantly in the isthmus area, while chief cells show scattered multi-color labeling 
(Figure 1F–1G). These data indicate that Mist1+ isthmus cell is the major source of lineage 
tracing of corpus glands.
In this period, Mist1+ cells gave rise to mucus neck cells (GS-II), parietal cells (H/K-
ATPase), surface pit cells (TFF1), tuft cells (Dclk1), and ECL cells (chromogranin A), while 
initially Mist1+ cells were negative for these markers (Figure S1F–S1G). Mist1+ chief cells 
at the base of glands are as expected positive for GIF at day 2 after TAM, while the Mist1+ 
isthmus cells are GIF-negative (Figure S1H). However, the early traced GIF+ chief cells at 
the base of glands decreased over time with an increase of traced GIF− isthmus cells (Figure 
S1I–S1J). Thus, Mist1+ basal chief cells are labeled by initial TAM induction, but that these 
cells turn over and disappear, finally to be renewed from the isthmus-derived Mist1+ stem 
cell.
Mist1+ isthmus cells are responsible for gastric lineage tracing
We confirmed no overlap between Mist1+ cells and reported gastric stem cell markers 
Cckbr+ or Sox2+ (Arnold et al., 2011; Hayakawa et al., 2015) (Figure S1K–S1L). Since 
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chief cells have also been shown to be Lgr5+ (Stange et al., 2013), we generated Mist1-
CreERT2;Lgr5-DTR-GFP;R26-Tdtomato mice (Tian et al., 2011). Similar to GIF staining, 
the vast majority of Mist1+ chief cells at the base are Lgr5+, whereas the Mist1+ isthmus 
cells are Lgr5− (Figure 1H). Thus, we ablated Lgr5+ cells, which included Mist1+ chief 
cells, by administration of diphtheria toxin (DT) (Figure S1M). After giving TAM and DT, 
100% of labeled chief cells were ablated (Figure 1I–1J, S1N). The expression of Lgr5 or Gif 
was markedly reduced by DT ablation (Figure S1O). However, the number of isthmus 
Mist1+ cells was even increased, and lineage tracing occurred at same frequency as the 
control (non-DT) group, accompanied with faster cell division (Figure 1I, 1K, S1P–S1S). 
After 6 months, the isthmus Mist1+ cells gave rise to chief cells. Similarly, ablation of chief 
cells by the elastase inhibitor DMP-777 (Nomura et al., 2005) did not affect the frequency of 
lineage tracing (Figure S1T–S1W). In contrast, when we treated mice with 5-Fluorouracil 
(5-FU) to kill isthmus stem/progenitor cells (Figure S1X–S1Y) (Stange et al., 2013), the 
mice showed almost no lineage tracing events but maintained a similar number of labeled 
chief cells at the gland base for 6 months (Figure 1L–1N). Thus, Mist1+ isthmus cells, and 
not Mist1+ chief cells, are responsible for lineage tracing in the corpus.
Isthmus Mist1+ cells give rise to intestinal-type metaplasia and cancer
In the isthmus, 1.1% of the Mist1+ cells were Ki67+ (Figure 2A), thus, more than 98% of 
Mist1+ isthmus stem cells are quiescent. KRAS is one of the most commonly mutated proto-
oncogenes in a variety of cancers, including gastric cancer. To investigate the effect of Kras 
mutation in gastric stem cells, we crossed Mist1-CreERT2 mice to LSL-KrasG12D mutant 
mice. Kras mutation in Mist1+ isthmus cells resulted in an increased percentage of 
Ki67+Mist1+ cells and overall faster cell division (Figure S2A–S2C). These cells formed 
Ki67+ dysplastic foci in the isthmus, which contained Alcian blue positive metaplastic cells 
(Figure 2B–2D). The metaplastic/dysplastic foci moved from the isthmus to the bottom of 
glands with loss of parietal cells and chief cells, and eventually replaced the entire glands 
with intestinal metaplasia (IM) and dysplasia (Figure S2D). We generated Mist1-
CreERT2;LSL-KrasG12D;Lgr5-DTR mice, and ablated isthmus cells and chief cells by 
giving 5-FU and DT, accordingly, after TAM induction (Figure S2E). Strikingly, 5-FU 
inhibited the metaplasia development, while DT ablation did not (Figure 2E–2F), indicating 
that the Mist1+ isthmus cells, and not the Mist1+ chief cells, are an origin of Kras-induced 
IM and dysplasia.
Aberrant activation of the Wnt signaling pathway by inactivating Apc is a common initiating 
event in many gastrointestinal tumors (Barker et al., 2010; Barker et al., 2009). Thus, we 
established Mist1-CreERT2;Apcflox/flox mice. Nuclear accumulation of β-catenin was 
observed in the Mist1+ lineage (isthmus and chief cells). However, nuclear β-catenin+ cells 
in corpus Mist1+ cells did not form dysplasia at later time points (up to 8 months) (Figure 
2G–2H), which seems contrary to the phenotype of Apc loss in stem cells in the gastric 
antrum, small intestine, and colon. In fact, whereas Wnt inhibition by Dickkopf-1 (DKK1) 
overexpression leads to marked decrease in proliferation in the intestine and colon, 
proliferation in the corpus was not inhibited (Figure S2F–S2G), suggesting that tumor 
initiation or proliferation in the corpus is likely independent of Wnt/β-catenin signaling.
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IM in the stomach is a known risk factor or precursor lesion for IGC. Thus, we attempted to 
induce Wnt/β-catenin activation in the presence of IM. We generated Mist1-CreERT2;LSL-
KrasG12D;Apcflox/flox mice, and this mouse developed intramucosal IGC with the expansion 
of nuclear β-catenin+ cells in 4 months (Figure 2I). Thus, Mist1+ stem cells can give rise to 
IGC with loss of Apc only when Kras-induced IM is also present. Notch signaling is another 
important pathway regulating gastric proliferation (Kim and Shivdasani, 2011). The Notch 
inhibitor dibenzazepine (DBZ) reduced the expansion of Mist1-lineage tracing as well as 
proliferation in the isthmus (Figure S2H–S2K), and constitutive activation of Notch 
signaling in Mist1+ stem cells by generating Mist1-CreERT2;Eef1a1-LSL-Notch1(IC) mice 
(Buonamici et al., 2009) resulted in the development of IGC (Figure S2L). Although Mist1 
protein expression is decreased in Kras/Apc-induced IGC, aberrant Notch activation 
increased the number of Mist1+ cells in tumor (Figure S1Q, S2M). The dysplastic cells in 
Notch-induced tumor did not display nuclear β-catenin accumulation, suggesting that in the 
corpus, Notch signaling is a Wnt-independent oncogenic pathway through which Mist1+ 
stem cells can progress to IGC.
Mist1+ isthmus cells can form corpus organoids in a Lgr5-independent fashion
To evaluate the stem cell properties of Mist1+ cells in vitro, we isolated corpus glands from 
Mist1-CreERT2;R26-mTmG mice 1 day following TAM induction. Mist1+ green cells were 
observed in the 2 distinct positions, and Mist1+ isthmus cells expanded to form cystic 
organoids in the reported culture method (Stange et al., 2013), while Mist1+ chief cells 
remained as single cells and eventually disappeared (Figure 3A). The GFP+ Mist1-derived 
cells survived in vitro for at least 2 months, confirming longevity. Even after ablation of 
Lgr5+ chief cells in Mist1-CreERT2;Lgr5-DTR;R26-TdTomato mice by DT injection, 
isthmus Mist1+ cells continued to lineage trace and give rise to chief cells in cultured 
organoids (Figure 3B–3C). We next sorted Mist1+ cells after DT or 5-FU treatment to the 
mice (lacking chief cells and isthmus cells, respectively) (Figure 3D–3F). Colony formation 
efficiency increased in the DT-treated group and decreased in the 5-FU-treated group, 
suggesting that isthmus Mist1+ cells are the true corpus stem cells, rather than Mist1+ chief 
cells. We compared gene expression patterns between the total Mist1+ population (majority 
of which were chief cells), DT-ablated isthmus Mist1+ population, and the differentiated 
parietal cell population (Figure S3A). Lgr5 and Gif expression are markedly downregulated 
in isthmus Mist1+ cells compared to total Mist1+ cells. Mist1 expression is upregulated in 
both total and isthmus Mist1+ population. The expression of several stem/progenitor 
markers, such as Cd44 and Sox9, or target genes of Wnt and Notch signaling, such as 
Ccnd1, Notch1, and Hes1, remain at higher levels in the isthmus population, suggesting that 
isthmus Mist1+ cells are Lgr5− but still exhibit stem cell characteristics.
The Wnt3a/R-spondin1 (W3a/Rspo1)-dependent culture system fails to produce corpus-
specific cell lineage such as parietal cells and ECL cells (Stange et al., 2013). Instead, 
W3aENR media (W3a, EGF, Noggin, and Rspo1) induces marked upregulation of Lgr5 (3-
times higher than gastric antrum organoids) (Figure 3G). Compared to standard W3aENR 
media, culture of corpus glands in ENJ media (where Wnt3a/Rspo1 were replaced by Notch 
ligand Jagged-1) led to decreased expression of Lgr5 or Gif, suggesting that Wnt3a/Rspo1 
lead to expansion of chief cells. In contrast, in ENJ media, we observed greater amounts of 
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parietal cells and ECL cells than in W3aENR media both in RT-PCR and immunostaining 
assays (Figure 3G and S3B), suggesting that the activation of Notch signaling is more 
important for preserving mature corpus cell types in culture than canonical Wnt signaling. 
Addition of a γ-secretase inhibitor blocked corpus organoid growth (Figure S3C–S3D), thus 
Notch signaling is important for corpus stem cell maintenance and growth. When we 
cultured Mist1-CreERT2;Lgr5-DTR;R26-TdTomato glands, antral and corpus organoids 
cultured with W3aENR did not grow and died following DT treatment (Figure 3H–3I), 
indicating that organoid growth is highly dependent on Lgr5+ cells in W3aENR media. 
However, lineage-traced corpus organoids survived with ENJ plus DT media (Figure S3E), 
proving that a non-Lgr5 stem cell population maintains organoid growth in Wnt3a/Rspo1-
independent culture conditions.
Cxcl12+ endothelium and Cxcr4+ ILCs contribute to the corpus stem cell niche through 
Wnt5a production
Given our in vitro data suggesting that Wnt3a or canonical Wnt signaling is not a critical 
niche factor in the corpus, we explored which Wnt ligands are indeed expressed in the 
stomach and intestine (Figure 4A and S4A). Among known Wnt ligands, Wnt3a expression 
was quite low in the corpus, in contrast to the intestine. Instead, an atypical Wnt ligand, 
Wnt5a, was highly expressed in the corpus. In situ hybridization of Wnt5a revealed focal 
expression in the isthmus stroma (Figure 4B) coincident with the known expression of 
Cxcr4 (Shibata et al., 2013). In Cxcr4-EGFP mice, Cxcr4+ cells were found in the isthmus 
area as rare single cells, showing almost identical distribution to Wnt5a expression (Figure 
4C). Cxcr4+ cells and Mist1+ cells represent distinct populations, although they were located 
in close proximity within the isthmus (Figure 4D).
Immunostaining revealed that Cxcr4+ cells in the corpus are negative for E-cadherin or 
stromal markers, αSMA, NG2, and S100B, but positive for CD45, suggesting that they are 
tissue-resident hematopoietic cells recruited to the isthmus (Figure 4E and S4B). About 60% 
of gastric CD45+Cxcr4+ cells from the whole gastric corpus are CD11b+ myeloid lineages 
(Figure S4C). CD3+ T cells, CD19+ B cells, and NK1.1+ classical NK cells are Cxcr4−. The 
remaining 40% of CD45+Cxcr4+ cells are Lineage-negative 
(CD3−Gr1−CD11b−CD45R−Ter119−), and about half of the Lin−Cxcr4+ population is a 
CD90.2+CD127+ lymphoid population (Figure 4F, S4C). The other half is predominantly c-
kit+FcεRIɑ+ mast cells. Immunostaining defined the isthmus Cxcr4+ cells as Lin−CD90.2+ 
intraepithelial gastric innate lymphoid cells (ILCs) (Figure 4E, S4D). Id2-GFP mice, which 
mark all types of ILCs (Hoyler et al., 2012), show similar distribution pattern as Cxcr4+ 
cells (Figure S4E). The majority (90%) of gastric Cxcr4+ ILCs are NKp46−CD4−, 
ScaI+ICOS+KLRG+ ILC2 cells, and a small population (5%) are Rorgt+NKp46− ILC3 cells 
(Figure 4F, S4F). In fact, gastric Cxcr4+ ILC population is enriched with ILC2-specific 
genes (Figure S4G).
In the sorted Mist1+ cells and Cxcr4+ cells, Wnt5a was expressed primarily in the Cxcr4+ 
cells (Figure S4H–S4I), confirming our in situ hybridization findings. When we treated 
Cxcr4+ cells with Cxcl12 in vitro, Wnt5a expression was upregulated (Figure S4J). We 
hypothesized that the Cxcr4+ cell might be a niche cell, supporting gastric stem cell 
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function. To test this possibility, we performed a co-culture experiment with “red” Mist1+ 
cells and “green” Cxcr4+ cells. Co-culture of Mist1+ cells with Cxcr4+ cells significantly 
enhanced “red” colony formation ability (Figure 4G–4H). Treatment with Cxcl12 
demonstrated an additive effect on Cxcr4+ cell co-culture, while it had no effect on Mist1+ 
cell culture alone, indicating that Cxcl12 acts through the Cxcr4+ ILCs. Furthermore, the 
Cxcr4+ ILC population exhibits the highest expression of Wnt5a compared to CD45+Cxcr4− 
cells or Cxcr4+ non-ILCs (Figure 4I). The colony formation ability of Mist1+ stem cells is 
enhanced by Wnt5a or co-culture with Cxcr4+ ILC population. However, Wnt5a-deficient 
ILCs which are sorted from Cag-CreERT2;Wnt5aflox/flox mouse stomach after TAM 
induction failed to show the same effect (Figure 4J). Thus, Cxcr4+ILC-derived Wnt5a plays 
a key role for promoting Mist1+ stem cell colony formation.
We explored the source of Cxcl12 in the stomach. In Cxcl12-dsRED mice (Ding and 
Morrison, 2013), there were frequent dsRED+ cells in the stroma near the isthmus (Figure 
4K). Indeed, Cxcr4+ ILCs and Cxcl12+ stromal cells in Cxcr4-EGFP;Cxcl12-dsRED mice 
were frequently positioned in close proximity (Figure 4L–4M). We confirmed that Cxcl12+ 
cells are CD31+ and endomucin+ endothelial cells (Figure 4N and S4K). We compared RNA 
expression between dsRED+CD31+ cells (35% of total CD31+ cells) and dsRED−CD31+ 
cells by qRT-PCR array (Figure S4L and Table S1). Among pathways potentially involved 
in the regulation of Cxcl12 expression, we found that Cxcl12+ cells express BMP receptor 2, 
and BMP2 treatment in vitro upregulates Cxcl12 expression (Figure S4M–S4N), consistent 
with previous findings (Yang et al., 2008). Interestingly, Tie2-Cre;Cxcl12flox/flox;Cxcr4-
EGFP mice, with targeted knockout of Cxcl12 in endothelial cells, displayed a significant 
reduction in the number of Cxcr4+ cells in the isthmus compared to control mice (Figure 
4O–4P). Together, endothelial Cxcl12 is important for the recruitment of Wnt5a-producing 
Cxcr4+ ILCs in the stomach.
E-cadherin loss in Mist1+ cells develops diffuse-type cancer dependent on chronic 
inflammation
We sought to establish whether Mist1+ stem cells were also a cell of origin for the diffuse 
gastric cancer (DGC) by knocking out Cdh1 gene in Mist1+ cells. Mist1-
CreERT2;Cdh1flox/flox mice (Cdh1ΔMist1) developed the pathognomonic, small mucous-
producing atypical cell foci in the isthmus of Cdh1ΔMist1 mice 10 days after TAM, but not in 
the chief cell region (Figure 5A–5B). E-cadherin was downregulated in these atypical 
appearing isthmus cells, consistent with early signet-ring cell morphology, recapitulating the 
earliest events in the pathogenesis of human signet-ring cell carcinoma. Ablation of chief 
cells and isthmus cells by DT and 5-FU treatment with Mist1-CreERT2;Cdh1flox/flox; Lgr5-
DTR mice confirmed that the isthmus Mist1+ cells are an origin of signet-ring cells (Figure 
S5A–S5B). Cxcl12/Cxcr4 niche cells were not affected by 5-FU treatment (not shown).
Nevertheless, the number of atypical cells gradually declined and disappeared (Figure 5C), 
suggesting that E-cadherin loss leads to epithelial cell death and is on its own insufficient to 
initiate DGC. Given that mild inflammation without gastric atrophy is a common feature of 
DGC (Carneiro et al., 2004), we infected TAM-induced Cdh1ΔMist1 mice with Helicobacter 
felis (Hf) to induce chronic inflammation. Surprisingly, in mice with Hf infection, atypical 
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foci were preserved and expanded even after 1 year TAM induction (Figure 5C). Lineage-
traced DGC with numerous signet ring cells was detected at 18 months post Hf infection in 
Cdh1ΔMist1 mice (Figure 5D, 7 of 9 mice (78%)), along with the increase of Mist1+ cells in 
DGC (Figure S1Q, S5C). Addition of Trp53 mutation in this setting lead to invasive DGC 
within 9 months (Figure S5D). Interestingly, administration of dexamethasone to Hf-
infected Cdh1ΔMist1 mice reduced the number of signet-ring cell foci to the same level as 
non-infected control mice (Figure 5E–5G). In contrast, another inflammation-associated 
cancer model, H/K-ATPase-IL-1β transgenic mice (Tu et al., 2008), also showed a dramatic 
expansion of lineage-traced signet-ring cells when crossed to Cdh1ΔMist1 mice, even without 
Hf infection (Figure 5H–5J). Thus, DGC development derived from Mist1+ stem cells is 
dependent on chronic inflammation, and that anti-inflammatory therapy may be useful for 
preventing DGC.
Although Troy+ chief cells are reported to act as reserve stem cells (Stange et al., 2013), we 
observed a rare Troy+ population in the isthmus that could lineage trace and give rise to 
cancers by examining Troy-BAC-CreERT2 mice (Fafilek et al., 2013) (Figure S6A–S6G). 
Also, while Troy+ chief cells are not proliferating and do not lineage trace in mice which 
preserving intact Troy expression, loss of Troy expression significantly promoted chief cell 
proliferation and lineage tracing after injury (Figure S6H–S6L), similar in most respects to 
the previous report, reconciling our findings with those of earlier groups (Stange et al., 
2013).
Cxcl12/Cxcr4 perivascular niche regulates DGC progression through Wnt5a production
During DGC development under chronic inflammation, corpus stem cell niche factors - 
Cxcl12+ endothelium and Cxcr4+ ILCs - are markedly expanded or upregulated in the 
region surrounding the isthmus DGC lesion (Figure 6A–6E, suggesting that these niche 
factors contribute to DGC development. We tested therapeutic intervention with AMD3100, 
a specific inhibitor of CXCR4, and an anti-CD90.2 antibody (Ab) for specific depletion of 
ILCs. Compared with vehicle-injected control mice, AMD3100 and the anti-CD90.2 Ab 
significantly reduced the number of signet-ring cell foci (Figure 6F–6H). In contrast, 
overexpression of Cxcl12 in Mist1-CreERT2;H/K-ATPase-Cxcl12;Cdh1flox/flox mice led to 
persistence and growth of DGC lesions over 3 months even without Hf infection (Figure 6I–
6K). Hf infection further accelerated DGC progression in this mouse model, while anti-
CD90.2 Ab treatment significantly reduced the number of DGC foci in the setting of Cxcl12 
overexpression (Figure S6M–S6N). Thus, upregulation of Cxcl12/Cxcr4 signaling through 
activation of ILCs plays a central role in DGC development.
After Hf infection, Wnt5a is highly upregulated in the stroma surrounding signet-ring lesions 
in the isthmus (Figure 6L). In addition, AMD3100 and anti-CD90.2 Ab treatment, or 
knockout of Cxcl12 in Tie2-lineage, significantly decreased the number of Cxcr4+ cells in 
the isthmus and the expression of Wnt5a, while Cxcl12-overexpression led to an increase in 
Cxcr4+ cell number and upregulation of Wnt5a (Figure 6M and S6O). Thus we tested the 
contribution of Wnt5a in DGC development by transplanting Cag-CreERT; Wnt5aflox/flox 
mouse bone marrow cells into Cdh1ΔMist1 mice (Figure 6N). In these chimeric mice, E-
cadherin is depleted in the Mist1+ lineage and Wnt5a is knocked out in bone-marrow 
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derived ILCs after TAM induction. Cdh1ΔMist1 mice with Cag-CreERT;Wnt5aflox/flox bone 
marrow exhibited significantly fewer signet-ring cell foci compared to Cdh1ΔMist1 mice with 
WT bone marrow cells (Figure 6O–6P), indicating that Wnt5a in the hematopoietic cells 
promotes DGC progression. Although there was a significant increase in the number of 
Cxcr4+ cells in Kras-induced IGC model, AMD3100 failed to block either Kras or Notch-
dependent IGC progression (Figure S6P–S6Q), suggesting the more predominant role of this 
pathway in DGC development.
RhoA activation by Wnt5a plays a role in DGC development
Wnt5a is known to activate a small GTPase protein, RhoA, which has a prosurvival effect 
by inhibiting anoikis in gastric and other cancer cells (Cai et al., 2008; Liu et al., 2013). 
Thus, we hypothesized that ILC-derived Wnt5a activates RhoA in E-cadherin-depleted cells 
and prolongs cell survival. We confirmed that Wnt5a activates RhoA in a CDH1 mutant 
AGS cells by immunoprecipitation (Figure 7A). In a soft-agar assay, treatment of AGS cells 
with Wnt5a enhanced sphere formation, indicating that Wnt5a promotes anchorage-
independent cell growth. Interestingly, blocking RhoA activation using a Rho inhibitor, 
Rhosin, diminished Wnt5a-mediated effects (Figure 7B–7C). Similar results were observed 
with another DGC cell line, KATO-III. Furthermore, we found that E-cadherin-deficient 
Mist1+ stem cells, which are normally unable to survive in vitro upon Cdh1 deletion, 
displayed prolonged survival in the presence of Wnt5a (Figure 7D–7E). This prosurvival 
effect was blocked by Rhosin, suggesting that Wnt5a-mediated RhoA activation is a key 
event for the survival of Cdh1-deleted organoids. However, Wnt5a did not affect the 
expansion of Kras or Notch-induced IGC organoids (not shown).
We compared these murine DGC findings with human DGC samples. Histologically, the 
DGC lesions in the Cdh1ΔMist1 mice appeared quite similar to early DGC with E-cadherin 
loss in patient samples (Figure 7F). Importantly, Cxcl12+ cells were found in stromal cells 
that appeared similar histologically to blood vessels, with KLRG1+ lymphocytes 
surrounding the signet-ring cancer cells, consistent with a role for these cells in supporting 
the DGC stem cell niche.
Discussion
In this study, we report 4 major discoveries regarding gastric stem cell and cancer biology: 
(1) quiescent Mist1+ gastric stem cells located at the isthmus of the corpus gland are an 
origin of all epithelial lineages, (2) they can serve as a cellular origin of all histological types 
of gastric cancer, (3) the Cxcl12/Cxcr4 axis comprising endothelial cells and ILCs regulates 
the normal and neoplastic gastric stem cell niche, and (4) Wnt5a from Cxcr4+ ILCs 
promotes diffuse-type cancer growth by activating RhoA. Our data provide a focus for 
gastric regeneration and cancer prevention and therapy.
In the gastric corpus, the isthmus is the major site of epithelial proliferation, and for many 
years has been thought to contain the “granule free” stem cell population (Karam and 
Leblond, 1993). We found that the isthmus Mist1+ cells are these granule-free bona fide 
stem cells in the corpus, which are remarkably quiescent, dividing infrequently (every 5 
days), consistent with the original expectations for mammalian adult stem cells (Malam and 
Hayakawa et al. Page 10









Cohn, 2014). It has been hypothesized that corpus glands may possess 2 different stem cell 
zones, isthmus and chief cells (Nam et al., 2010; Stange et al., 2013). Our ablation 
experiments using 5-FU and Lgr5-DT system find that only isthmus cells, not chief cells, 
play a predominant role in maintaining the gastric gland and are an origin of gastric cancer. 
The gradient of BMP or Shh expression determines the localized expression of Lgr5 at the 
gastrointestinal gland base (Shyer et al., 2015), and basal chief cells in the corpus express 
Lgr5. Thus, our model suggests that Lgr5 expression may not always reflect actual 
stemness, especially in a Wnt-independent organ.
Lineage-tracing studies have been based largely on TAM-induced Cre activation, but TAM 
treatment may cause epithelial cell death and influence stem cell activity (Huh et al., 2012; 
Zhu et al., 2013). Given that Troy is known to have an inhibitory effect on Wnt signaling, 
the knockin Troy lineage tracing may be related to a reduction in Troy expression in the 
knockin mice, secondary to haploinsufficiency, resulting in enhanced Wnt signaling activity 
in those mice. Whilst knockin lines have many potential advantages, disruption of even one 
copy of the endogenous gene can apparently alter certain phenotypes.
The Cxcl12/Cxcr4 perivascular niche in the bone marrow has previously been identified and 
studied as a major regulator of HSC (Ding and Morrison, 2013; Sugiyama et al., 2006). 
However, until now the role of the Cxcl12/Cxcr4 stem cell niche axis beyond the bone 
marrow has been unclear. In addition, Cxcl12 and Cxcr4 modulate the tumor 
microenvironment, and targeting this axis was an effective strategy in certain cancers (Pitt et 
al., 2015; Quante et al., 2011; Roccaro et al., 2014). Given that human DGCs are in general 
extremely resistant to current treatment regimens, anti-inflammatory drugs such as steroids 
or NSAIDs, as well as specific Cxcr4 antagonists, may be useful for chemoprevention of 
DGC, particularly for hereditary-type DGC prior to gastrectomy, and/or for prevention of 
recurrent disease.
E-cadherin is essential for epithelial cell survival under normal conditions (Schneider et al., 
2010) and loss of E-cadherin causes cell anoikis (Kantak and Kramer, 1998). Previous 
studies suggest that Cxcr4 and Wnt5a are upregulated in human gastric cancer tissues (Iwasa 
et al., 2009; Kanzawa et al., 2013). Recent genome-wide analyses revealed in human DGCs 
the presence of gain-of-function RHOA mutations that can inhibit anoikis (Cancer Genome 
Atlas Research, 2014; Kakiuchi et al., 2014; Wang et al., 2014). Thus, the activation of 
RhoA signaling, either by gene mutation or Wnt5a-mediated effect, may be essential for the 
development of DGC.
Wnt5a is a representative ligand that activates noncanonical Wnt signaling by binding to 
Ror2 to regulate cell migration, polarity, proliferation, or invasion. Wnt5a is expressed in 
gut stroma, and contributes to intestinal elongation and colonic regeneration, however, the 
precise source of stromal Wnt5a has been unclear (Cervantes et al., 2009; Gregorieff et al., 
2005; Miyoshi et al., 2012). We propose ILCs as a major source of Wnt5a, at least in the 
stomach. The function of ILCs has been highlighted in the setting of inflammatory or 
infectious states, although the possibility has been raised of a role for ILCs in stem cell niche 
or cancer development (Bando et al., 2015; Hanash et al., 2012; Kirchberger et al., 2013). 
Our findings would support this model, and given that ILCs are a heterogeneous population 
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of immune cells, further efforts at detailed profiling of the ILC population in stem cell niche 
and cancer are needed.
Experimental Procedures
Mice
Mist1-CreERT2 mice (Shi et al., 2009), Cxcl12-dsRED mice (Ding and Morrison, 2013), 
Troy−/− and Troy-BAC-CreERT2 mice (Fafilek et al., 2013), H/K-ATPase-Cxcl12 mice 
(Shibata et al., 2013), Eef1a1-LSL-Notch1(IC) mice (Buonamici et al., 2009), Wnt5aflox 
mice (Miyoshi et al., 2012) were described previously. Cxcr4-EGFP mice were kindly 
provided by Richard J. Miller (Northwestern University Medical School, USA). LSL-
KrasG12D and LSL-Trp53R172H mice were provided by Dr. Kenneth Olive (Columbia 
University, USA). Apcflox mice were obtained from the National Cancer Institute (NCI). 
Lgr5-DTR-GFP mice were provided by Genentech. Cdh1flox, R26-mTmG, R26-LacZ, R26-
TdTomato, R26-Confetti, R26-EYFP, Cxcl12flox, Tie2-Cre, Id2-GFP, and Cag-CreERT2 
mice were purchased from the Jackson Laboratory. Cre recombinase was activated by oral 
administration of TAM (1–5mg/0.2mL corn oil, as indicated). All animal studies and 
procedures were approved by the ethics committees at Columbia University and the 
Academy of Sciences of the Czech Republic. Human stomach tissue sections were obtained 
from DGC patients who underwent surgical resection or endoscopic submucosal dissection 
from 2001 to 2012 at Gifu University Hospital, Gifu, Japan. All study protocols were 
approved by the ethics committees, and written informed consent was obtained from all 
patients.
Treatment
5-FU (Sigma) was administered intraperitoneally (i.p.) at a dose of 150 mg/kg. DMP-777 
was given as described previously (Nam et al., 2010). DBZ was dissolved in 10% dimethyl 
sulfoxide and injected i.p. (30 μmol/kg) for 14 days. For Lgr5+ cell ablation, DT was 
administered i.p. at a dose of 20 mg/kg. Mice were treated with 5 mg/kg AMD3100 (Tocris) 
to inhibit Cxcr4 for 2 weeks, as described previously (Quante et al., 2011). Dexamethasone 
(Sigma) was administered i.p. at a dose of 5 mg/kg for 2 weeks. CD90.2 mAb (30H12) 
(BioXCell, West Lebanon, NH) was administered i.p. every 2 days at a dose of 250 mg/
mouse for 4 weeks. Control groups were treated with appropriate vehicles or control 
antibodies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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We identified a quiescent stem cell in the corpus isthmus, which can give rise to gastric 
cancer. We also discovered a Cxcl12/Cxcr4 perivascular niche in the stomach, which 
supports normal and neoplastic stem cells through Wnt5a production.
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Figure 1. Mist1 is a marker of quiescent stem cells in the corpus isthmus
(A) The corpus of Mist1-CreERT2;R26-mTmG mice day 1 after 3 mg TAM. Left: chief 
cells; right: isthmus cells (arrow). (B) Electron microscopy of Mist1+ cells in the isthmus. 
(C) Lineage tracing in Mist1-CreERT2;R26-mTmG mice from day 1 – 540. The arrow 
indicates the isthmus cells. (D) Mist1-traced cell position. Total 50 glands are analyzed at 
each time points. (E) The number of traced glands per 100 glands at 3, 6, and 12 months. 
Total 300 glands from 3 mice are used at each time points. (F–G) Mist1-CreERT2;R26-
Confetti mice 8 months after TAM (F). Single color and multi-color clones in the isthmus 
and chief cells are quantified (G). Total 50 glands are analyzed. (H–I) Mist1-CreERT2;Lgr5-
DTR-GFP (green);R26-TdTomato (red) mouse corpus 24 hr after TAM (H), and 2, 5, 10, 
and 180 days after TAM + DT ablation (I). Yellow arrows; Mist1+ isthmus cell tracing, 
green arrows; Lgr5+ chief cells. (J–K) The numbers of labeled chief cells per gland (J, day 
4) and lineage tracing events per 100 gland (K, day 30) with or without DT ablation. (L) 
Lineage tracing in 5-FU-treated Mist1-CreERT2;R26-mTmG mouse corpus. Refer to Figure 
1C for control images. (M–N) The numbers of labeled chief cells per gland 4 days after 
TAM (cont) or TAM + 5-FU (5-FU) treatments (M) and the number of lineage tracing 
events per 100 gland on day 30 (N). Total 500 glands from 5 mice/group are analyzed for 
(J–K) and (M–N). Bars=1 μm (B), 10 μm (A, C, F, H–I, L). Means ± SEM. *p < 0.05. See 
also Figure S1.
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Figure 2. Mist1+ isthmus cells give rise to IM and IGC
(A) Ki67 (red) and GFP staining (green) of Mist1-CreERT2;R26-mTmG mice at day2. (B–
D) H&E (B), Ki67 (C), and alcian blue (D) staining in Mist1-CreERT2;LSL-KrasG12D mice 
on days 14, 21, and 28 after induction. Arrows indicate itshmus-derived dysplastic cells. (E–
F) H&E staining (E) and numbers of metaplastic glands per 100 glands (F) of Mist1-
CreERT2;LSL-KrasG12D;Lgr5-DTR-GFP mice treated with PBS (left), 5-FU (middle), or 
DT (right) 30 days after TAM. Total 300 glands from 3 mice/group are analyzed. (G–H) 
H&E (G, day 240) and β-catenin (H) staining in Mist1-CreERT2;Apcflox/flox mouse. Arrows 
indicate nuclear β-catenin+ cells. (I) H&E (left) and β-catenin (right) staining in Mist1-
CreERT2;LSL-KrasG12D;Apcflox/flox mouse corpus on day 120 post-induction. Means ± 
SEM. *p < 0.05. Bars=10 μm (A), 100 μm (B–E, G–I). See also Figure S2.
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Figure 3. Mist1+ isthmus cells can form corpus organoids in a Lgr5-independent fashion
(A) Corpus gland culture of TAM-induced Mist1-CreERT2;R26-mTmG mice. Yellow 
arrows; isthmus cells, white arrows; chief cells. (B–C) Lineage tracing (B) and GIF staining 
(C, green) of corpus gland culture from Mist1-CreERT2;Lgr5-DTR-GFP;R26-TdTomato 
mice treated with DT. (D–F) TdTomato+ cells were sorted and cultured from DT or 5-FU-
treated Mist1-CreERT2;Lgr5-DTR-GFP;R26-TdTomato mice corpus after TAM. FACS plot 
(D), images (E), and colony formation efficiency (F) at day 7 are shown. n = 4/group. (G) 
Relative gene expression per Gapdh in antral or corpus organoids cultured with the indicated 
media for 10 days. n = 3/group. (H–I) Organoid growth of antrum and corpus glands 
cultured with W3aENR or ENJ media. Day 10 images (H) and the relative numbers of 
organoids cultured in the indicated media (I). Numbers in non-DT organoids in each groups 
are set as 1.0. n = 3/group. Means ± SEM. *p < 0.05. Bars=50 μm. See also Figure S3.
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Figure 4. Cxcl12+ vascular endothelial and Cxcr4+ ILCs contribute to corpus stem cell niche 
through Wnt5a production
(A) Relative expression of Wnt3 and Wnt5a in the corpus, antrum, and small intestine. n = 3/
group. (B) In situ hybridization of Wnt5a in the corpus. Arrows indicate Wnt5a+ cells in the 
isthmus stroma. (C) GFP staining in the Cxcr4-EGFP mouse corpus gland. Arrows indicate 
GFP+ cells in the isthmus. (D) Lineage tracing in Mist1-CreERT2;Cxcr4-EGFP;R26-
TdTomato mice on days 2 and 14. Arrows indicate GFP+ cells. (E) E-cadherin (red), CD45 
(red), Lineage (blue), and CD90.2 (red) staining of Cxcr4-EGFP+ cells. (F) FACS plots of 
gastric Cxcr4+ cells. Top left; gating by CD45+ and Cxcr4-EGFP+. Top middle; gating by 
Lin−. Top right; ILCs are identified by IL-7R+CD90.2+. Bottom; histograms of indicated 
ILC markers. (G) Single-cell culture of Mist1+ cells (red) with or without Cxcr4+ cell 
(green) co-culture. (H) Relative colony forming efficiency of Mist1+ cells with Cxcl12 
treatment and Cxcr4+ cell co-culture. n = 4/group. Colony formation efficiency of control 
group is set as 1.0 in (H) and (J). (I) Wnt5a gene expression in Cxcr4+/− ILCs and non-ILC 
CD45+ cells. n = 3/group. (J) Relative colony forming efficiency of Mist1+ cells with Wnt5a 
(100 ng/ml), Cxcr4+ ILCs, or Cag-CreERT;Wnt5aflox/flox ILCs. n = 4/group. (K) Cxcl12-
dsRED mouse stomach with phalloidin staining (green). (L) Cxcr4-EGFP;Cxcl12-dsRED 
mouse stomach. (M) Cell positions of Cxcr4+ cells and Cxcl12+ cells. (N) Immunostaining 
(green) of CD31 in Cxcl12+ cells (red). (O–P) GFP expression (O) and the numbers of GFP+ 
cells (P) in Cxcr4-EGFP and Tie2-Cre;Cxcl12flox/flox;Cxcr4-EGFP mouse corpus. n = 30/
group. Means ± SEM, *p < 0.05. Bars=10 μm (B–E, K, N), 25 μm (G, L, O). See also Figure 
S4 and Table S1.
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Figure 5. E-cadherin loss in Mist1+ cells develops DGC dependent on chronic inflammation
(A–B) H&E and E-cadherin staining (A), and the location (B) of atypical foci in Cdh1ΔMist1 
mice (day 10). (C) Numbers of atypical foci per section with or without Hf infection. n = 3 
mice/group at each time points. (D) H&E staining (left) and GFP expression (right) in Hf-
infected Mist1-CreERT2;Cdh1flox/flox;R26-mTmG mice 18 months after TAM induction. 
(E) Protocols for TAM, Hf, and therapies (dexamethasone, AMD3100, and anti-CD90.2 
Ab). (F–G) H&E staining (F), and numbers of atypical foci per section (G) in Hf-infected 
Cdh1ΔMist1 mice treated with or without dexamethasone. n = 4 mice/group and 4 sections/
mouse are analyzed. (H–J) Numbers of atypical foci per section (H), H&E (I), and GFP 
staining (J) in Cdh1ΔMist1and Cdh1ΔMist1 mice crossed with H/K-ATPase-IL1β mice after 4 
months TAM induction. Means ± SEM. *p < 0.05. Bars=50 μm. See also Figure S5.
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Figure 6. Cxcl12/Cxcr4 perivascular niche regulates DGC progression through Wnt5a 
production
(A–E) E-cadherin (A) and CD90.2 staining (B) (red) of Mist1-CreERT2;Cdh1flox/flox;Cxcr4-
EGFP (green) mice, and Mist1-CreERT2;Cdh1flox/flox;Cxcl12-dsRED (red);Cxcr4-EGFP 
(green) (C) mice treated with TAM and Hf (6 months). Numbers of Cxcl12+ cells (D) and 
Cxcr4+CD90.2+ cells (E) per gland with or without Hf infection. Total 20 glands per group 
were analyzed. (F–H) H&E staining of Hf-infected Cdh1ΔMist1 mice treated with or without 
AMD3100 (F), or treated with control IgG Ab or anti-CD90.2 Ab (G). The numbers of 
atypical foci per section (H). n = 4 mice/group and 4 sections/mouse are analyzed. Arrows 
indicate atypical foci. (I–K) H&E (I) and E-cadherin (J) staining, and numbers of atypical 
foci per section (K) in Cdh1ΔMist1 mice crossed to H/K-ATPase-Cxcl12 mice 3 months after 
TAM. n = 3 mice/group and 4 sections/mouse are analyzed. Arrows indicate atypical foci. 
(L) In situ hybridization of Wnt5a in Cdh1ΔMist1 mice with or without Hf infection. (M) 
Cxcr4-EGFP expression in WT and H/K-ATPase-Cxcl12 mouse stomach treated with 
control, AMD-3100, or anti-CD90.2 Abs. (N–P) Control or Cag-CreERT;Wnt5aflox/flox 
mouse bone marrow cells were transplanted into Mist1-CreERT2;H/K-ATPase-
Cxcl12;Cdh1flox/flox mice after 10.5 Gy whole body irradiation (N). The numbers (O) of 
atypical foci per section and H&E staining (P) are shown. n = 4 mice/group and 4 sections/
mouse are analyzed. Arrows indicate atypical foci. Means ± SEM. *p < 0.05. Bars=50 μm 
(A–C, F–G, L–M), 100 μm (I–J, P). See also Figure S6.
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Figure 7. RhoA activation by Wnt5a plays a role in DGC development
(A) AGS cells were treated with 100 ng/ml Wnt5a for the indicated times. Cell lysates were 
immunoprecipitated with RhoA-GTP Ab and immunoblotted with total RhoA Ab. (B–C) 
Soft-agar sphere forming assay of Wnt5a-treated AGS and KATO-III cells. Cells were 
treated with vehicle or 30 μM Rhosin. Sphere images (B) and numbers (C) of spheres at day 
10. n = 4/group. (D–E) Corpus organoids from TAM-treated Mist1-CreERT2; Cdh1flox/flox; 
R26-mTmG mice treated with 100 ng/ml Wnt5a and/or 30 μM Rhosin. Images (D) and 
numbers (E) of GFP+Cdh1− organoids per total organoid number on days 3 and 14. n = 4/
group. (F) H&E, E-cadherin, Cxcl12, and KLRG1 staining in human DGC. Bars=100 μm 
(D), 50 μm (B, F). Means ± SEM. *p < 0.05.
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